Erin Wright
Stock Analyst at Morgan Stanley
(2.89)
# 1,474
Out of 5,129 analysts
251
Total ratings
66.67%
Success rate
30.74%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PSX Phillips 66 | Maintains: Equal-Weight | $140 → $147 | $157.31 | -6.55% | 3 | Feb 5, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $154 → $169 | $196.27 | -13.89% | 26 | Feb 5, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $181.30 | -4.03% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $360.00 | +11.11% | 2 | Jan 29, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $224 → $245 | $220.27 | +11.23% | 13 | Jan 29, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $35 → $38 | $33.15 | +14.63% | 2 | Jan 13, 2026 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $325.64 | +8.09% | 5 | Dec 18, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $18 → $22 | $25.61 | -14.10% | 12 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $75.70 | +22.85% | 7 | Dec 10, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $128.13 | +36.58% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $935.21 | -2.05% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $55 → $58 | $81.04 | -28.43% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $646.53 | +24.51% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $125.43 | +62.64% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $39.34 | -18.66% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $30.17 | -43.65% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $51.74 | -49.75% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $287.81 | +35.51% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.82 | +13.48% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $13.93 | +65.11% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $205.35 | -16.24% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $273.22 | +114.85% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $284.50 | +5.45% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $11.16 | +276.34% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $219.75 | +31.06% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $181.24 | +94.22% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.12 | +1,310.26% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $446.05 | -59.42% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $67.11 | -74.67% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $27.20 | +344.85% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $539.80 | +7.45% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $7.00 | +400.00% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $144.55 | +41.82% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $23.06 | -52.30% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $182.45 | -13.95% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $629.56 | -51.08% | 1 | Oct 25, 2017 |
Phillips 66
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $140 → $147
Current: $157.31
Upside: -6.55%
Align Technology
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $154 → $169
Current: $196.27
Upside: -13.89%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $181.30
Upside: -4.03%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $360.00
Upside: +11.11%
Cardinal Health
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $220.27
Upside: +11.23%
Option Care Health
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $33.15
Upside: +14.63%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $325.64
Upside: +8.09%
Elanco Animal Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $18 → $22
Current: $25.61
Upside: -14.10%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $75.70
Upside: +22.85%
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $128.13
Upside: +36.58%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $935.21
Upside: -2.05%
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $81.04
Upside: -28.43%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $646.53
Upside: +24.51%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $125.43
Upside: +62.64%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $39.34
Upside: -18.66%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $30.17
Upside: -43.65%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $51.74
Upside: -49.75%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $287.81
Upside: +35.51%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.82
Upside: +13.48%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $13.93
Upside: +65.11%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $205.35
Upside: -16.24%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $273.22
Upside: +114.85%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $284.50
Upside: +5.45%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $11.16
Upside: +276.34%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $219.75
Upside: +31.06%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $181.24
Upside: +94.22%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.12
Upside: +1,310.26%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $446.05
Upside: -59.42%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $67.11
Upside: -74.67%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $27.20
Upside: +344.85%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $539.80
Upside: +7.45%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $7.00
Upside: +400.00%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $144.55
Upside: +41.82%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $23.06
Upside: -52.30%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $182.45
Upside: -13.95%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $629.56
Upside: -51.08%